Ocean Biomedical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	-	0	0.03	0.06	-	-
Cash & Short-Term Investments	-	0	0.03	0.06	-	-
Cash Growth	-	-88.23%	-43.33%	-	-	-
Prepaid Expenses	0.8	1.11	-	-	-	-
Restricted Cash	0.24	1	-	-	-	-
Other Current Assets	-	-	1.81	0.02	0.39	-
Total Current Assets	1.04	2.11	1.84	0.08	0.39	-
Long-Term Investments	0.09	3.39	-	-	-	-
Total Assets	1.13	5.5	1.84	0.08	0.39	-
Accounts Payable	0.86	0.93	-	0.24	0.05	-
Accrued Expenses	16.38	15.25	11.44	6.33	2.14	0.23
Short-Term Debt	12.84	13.06	1.22	0.18	0.08	-
Other Current Liabilities	3.57	0.76	-	-	-	-
Total Current Liabilities	33.65	30.01	12.66	6.74	2.27	0.23
Long-Term Debt	5.16	4.12	-	-	-	-
Other Long-Term Liabilities	60.41	62.13	-	-	-	-
Total Liabilities	99.22	96.26	12.66	6.74	2.27	0.23
Additional Paid-In Capital	107.73	105.29	70.77	57.57	-	-
Retained Earnings	-205.82	-196.06	-81.59	-64.23	-1.89	-0.23
Shareholders' Equity	-98.09	-90.76	-10.82	-6.66	-1.89	-0.23
Total Liabilities & Equity	1.13	5.5	1.84	0.08	0.39	-
Total Debt	18	17.19	1.22	0.18	0.08	-
Net Cash (Debt)	-18	-17.18	-1.19	-0.12	-0.08	-
Net Cash Per Share	-0.66	-0.65	-0.05	-0.01	-0.00	-
Filing Date Shares Outstanding	34.87	34.82	23.36	17.5	17.45	17.45
Total Common Shares Outstanding	34.87	34.65	23.36	17.5	17.45	17.45
Working Capital	-32.61	-27.9	-10.82	-6.66	-1.89	-0.23
Book Value Per Share	-2.81	-2.62	-0.46	-0.38	-0.11	-0.01
Tangible Book Value	-98.09	-90.76	-10.82	-6.66	-1.89	-0.23
Tangible Book Value Per Share	-2.81	-2.62	-0.46	-0.38	-0.11	-0.01

Updated Jan 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q